echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Novavax will participate in the European World Vaccine Conference

    Novavax will participate in the European World Vaccine Conference

    • Last Update: 2021-11-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Gaithersburg, Maryland, October 18, 2021/PRNewswire/ - Novavax, Inc.


    During the European World Vaccine Congress 2021

    The meeting details are as follows:

    date: 

    Wednesday, October 20, 2021 

    time: 

    11:30 am – 12:00 pm Central European Time (CET) /


    title: 

    Novavax NanoFlu vaccine and new coronary pneumonia NanoFlu vaccine development update 

    Novavax participants: 

    Vivek Shinde, MD, Vice President of Clinical Development 

    date: 

    Wednesday, October 20, 2021 

    time: 

    11:30 am – 12:00 pm Central European Time (CET) /


    title: 

    Novavax NanoFlu vaccine and new coronary pneumonia NanoFlu vaccine development update 

    Novavax participants: 

    Vivek Shinde, MD, Vice President of Clinical Development 

    date: 

    Wednesday, October 20, 2021 


    11:30 am – 12:00 pm Central European Time (CET) /



    Novavax NanoFlu vaccine and new coronary pneumonia NanoFlu vaccine development update 


    Vivek Shinde, MD, Vice President of Clinical Development 


    Wednesday, October 20, 2021 

    date: 

    date: 

    Date:Date:

    Wednesday, October 20, 2021 

    Wednesday, October 20, 2021 

    Wednesday, October 20, 2021

    time: 

    11:30 am – 12:00 pm Central European Time (CET) /


    time: 

    time: 

    Time:time:

    11:30 am – 12:00 pm Central European Time (CET) /


    11:30 am – 12:00 pm Central European Time (CET) /


    11:30 am – 12:00 pm Central European Time (CET) /


    Novavax NanoFlu vaccine and new coronary pneumonia NanoFlu vaccine development update 

    title: 

    title: 

    Title:Title:

    Novavax NanoFlu vaccine and new coronary pneumonia NanoFlu vaccine development update 

    Novavax NanoFlu vaccine and new coronary pneumonia NanoFlu vaccine development update 

    Novavax NanoFlu vaccine and new coronary pneumonia NanoFlu vaccine development update

    Novavax participants: 

    Vivek Shinde, MD, Vice President of Clinical Development 

    Novavax participants: 

    Novavax participants: 

    Novavax participants:Novavax participants:

    Vivek Shinde, MD, Vice President of Clinical Development 

    Vivek Shinde, MD, Vice President of Clinical Development 

    Vivek Shinde, MD, Vice President of Clinical Development 

    For more information or registration, please visit the conference website


    Conference website

    About Novavax


    About Novavax

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.